NAMPT and metabolic dysfunction-associated steatotic liver disease: Another systematic review and meta-analysis evaluated serum visfatin levels in NAFLD, concluding that visfatin levels were not found to be associated with NAFLD, whether biopsy-proven or ultrasound-diagnosed, presence or severity of hepatic steatosis, liver fibrosis, lobar inflammation, or NASH [22].